Your browser doesn't support javascript.
loading
Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group.
Gerdtsson, Axel; Thor, Anna; Grenabo Bergdahl, Anna; Almås, Bjarte; Håkansson, Ulf; Törnblom, Magnus; Negaard, Helene F S; Glimelius, Ingrid; Halvorsen, Dag; Karlsdóttir, Ása; Sagstuen Haugnes, Hege; Engen Andreassen, Kristine; Melsen Larsen, Signe; Holmberg, Göran; Wahlqvist, Rolf; Tandstad, Torgrim; Cohn-Cedermark, Gabriella; Ståhl, Olof; Kjellman, Anders.
Afiliação
  • Gerdtsson A; Department of Clinical Science, Intervention and Technology, Division of Urology, Karolinska Institutet, Stockholm, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden. Electronic address: axel.gerdtsson@ki.se.
  • Thor A; Department of Clinical Science, Intervention and Technology, Division of Urology, Karolinska Institutet, Stockholm, Sweden; Department of Urology, Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.
  • Grenabo Bergdahl A; Department of Urology, Gothenburg University, Gothenburg, Sweden; Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Almås B; Department of Urology, Haukeland University Hospital, Bergen, Norway.
  • Håkansson U; Gastrocenter, Lund, Sweden.
  • Törnblom M; Department of Clinical Science and Education, Section of Urology, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden; Department of Surgery, Visby County Hospital, Visby, Sweden.
  • Negaard HFS; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Glimelius I; Department of Immunology, Genetics and Pathology, Unit of Clinical and Experimental Oncology, Uppsala University, Uppsala, Sweden.
  • Halvorsen D; Department of Urology, St. Olavs University Hospital, Trondheim, Norway.
  • Karlsdóttir Á; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • Sagstuen Haugnes H; Department of Oncology, University Hospital of North Norway, Tromsø, Norway; Department of Clinical Medicine, UIT-The Arctic University of Norway, Tromsø, Norway.
  • Engen Andreassen K; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Melsen Larsen S; Department of Urology, Oslo University Hospital, Oslo, Norway.
  • Holmberg G; Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Wahlqvist R; Department of Urology, Oslo University Hospital, Oslo, Norway.
  • Tandstad T; The Cancer Clinic, St. Olavs University Hospital, Trondheim, Norway; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
  • Cohn-Cedermark G; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Pelvic Cancer, Genitourinary Oncology Unit, Karolinska University Hospital, Stockholm, Sweden.
  • Ståhl O; Department of Oncology, Skåne University Hospital, Lund, Sweden; Department of Clinical Sciences, Lund University, Lund, Sweden.
  • Kjellman A; Department of Clinical Science, Intervention and Technology, Division of Urology, Karolinska Institutet, Stockholm, Sweden; Department of Urology, Pelvic Cancer, Karolinska University Hospital, Stockholm, Sweden.
Eur Urol Oncol ; 5(2): 235-243, 2022 04.
Article em En | MEDLINE | ID: mdl-33750683

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retroperitoneais / Teratoma / Neoplasias Testiculares / Neoplasias Embrionárias de Células Germinativas Tipo de estudo: Observational_studies Limite: Humans / Male País como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Retroperitoneais / Teratoma / Neoplasias Testiculares / Neoplasias Embrionárias de Células Germinativas Tipo de estudo: Observational_studies Limite: Humans / Male País como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article